Article in valneva FDA Approves World’s First Chikungunya Vaccine- Valneva’s Single Dose IXCHIQ IXCHIQ has received the approval of the United States Food and Drug Administration (US FDA) for use in adults who are 18 years and older. MORE FOR YOU World AIDS Day 2023: Myths And Facts About AIDS World AIDS Day: United Nations Say It Is Still Possible To End AIDS by 2030: Here's How 30% Of Postmenopausal Women Have Osteoporosis, Reveals Study: Here Are Preventive Measures To Combat It Study Reveals How Poor Oral Health Can Increase Your Risk Of Diabetes World AIDS Day 2023: How HIV Can Be Prevented From Developing Into AIDS Workplace Eye Wellness: Dry Eye Disease Can Impact Productivity At Work, Know Coping Tips From Expert